There are 34 papers on hidradenitis suppurativa in aging research: 2 trials and 9 observational studies in people, 1 in cells, 22 reviews.
3 new papers in 30 daysSee all 38 papers on hidradenitis suppurativa
“During follow-up, 8.2% of patients with HS initiated GLP-1RA treatment, compared with 5.7% of psoriasis patients and 3.2% of controls.”
- Human trial2
- Humans9
- Cells1
Interventions
3GLP-1 receptor agonists
downin humans1
1 study
GLP-1 receptor agonists
downin humans1
GLP-1 receptor agonists decrease hidradenitis suppurativa in humans (hidradenitis suppurativa).
Reviewhidradenitis suppurativa
Metformin
downin humans1
1 study
Metformin
downin humans1
Metformin decreases hidradenitis suppurativa in humans (hidradenitis suppurativa).
Reviewhidradenitis suppurativa
Semaglutide
downin humans1
1 study
Semaglutide
downin humans1
Semaglutide decreases hidradenitis suppurativa in humans (11.34 ± 4.56 to 7.45 ± 3.21).
Human trial24 monthsn = 110
Effects
5Transcriptomic clock
upin humans1
1 study
Transcriptomic clock
upin humans1
Hidradenitis suppurativa is linked with higher transcriptomic clock in humans (lesional vs healthy skin) (+5.0∼6.1y, t = 2.5∼4.1, P < .05).
Humanslesional vs healthy skinskin
GrimAge
downin humans1
1 study
GrimAge
downin humans1
Hidradenitis suppurativa is linked with lower GrimAge in humans (-5.14 years, p-value < 0.001).
Humansskin
PhenoAge
upin humans1
1 study
PhenoAge
upin humans1
Hidradenitis suppurativa is linked with higher PhenoAge in humans (7.72 years, p-value = 0.003).
Humansskin
Extrinsic epigenetic age acceleration
upin humans1
1 study
Extrinsic epigenetic age acceleration
upin humans1
Hidradenitis suppurativa is linked with higher Extrinsic epigenetic age acceleration in humans (13.72 years, p-value < 0.001).
Humansskin
Intrinsic epigenetic age acceleration
no changein humans1
1 study
Intrinsic epigenetic age acceleration
no changein humans1
Hidradenitis suppurativa was not clearly linked with intrinsic epigenetic age acceleration in humans (-1.00 years, p-value = 0.52).
Humansskin
Associations
10Obesity
upin reviews2
2 studies
Obesity
upin reviews2
Hidradenitis suppurativa is associated with obesity.
Review
Hidradenitis suppurativa is associated with obesity.
Review
Cardiometabolic comorbidities
upin humans1
1 study
Cardiometabolic comorbidities
upin humans1
Hidradenitis suppurativa is associated with cardiometabolic comorbidities in humans.
Humansindex date to GLP-1RA initiation
Time to GLP-1 receptor agonist initiation
downin humans1
1 study
Time to GLP-1 receptor agonist initiation
downin humans1
Hidradenitis suppurativa is associated with time to glp-1 receptor agonist initiation in humans (8.88 years vs 10.1 years (psoriasis) and 10.2 years (controls)).
Humans
GLP-1 receptor agonist initiation
upin humans1
1 study
GLP-1 receptor agonist initiation
upin humans1
Hidradenitis suppurativa is associated with glp-1 receptor agonist initiation in humans (8.2% vs 5.7% in psoriasis and 3.2% in controls).
Humansfollow-up
Osteoporosis
upin humans1
1 study
Osteoporosis
upin humans1
Hidradenitis suppurativa raises the risk of osteoporosis in humans.
Reviewfemales
Metformin
upin humans1
1 study
Metformin
upin humans1
Hidradenitis suppurativa is associated with metformin in humans (ever-use after HS diagnosis, compared with participants without HS) (aOR 3.39; 95% CI 3.04-3.77).
Humansever-use after HS diagnosis, compared with participants without HSn = 2,636
GLP-1 receptor agonists
upin humans1
1 study
GLP-1 receptor agonists
upin humans1
Hidradenitis suppurativa is associated with GLP-1 receptor agonists in humans (ever-use after HS diagnosis, compared with participants without HS) (aOR 3.30; 95% CI 2.90-3.75).
Humansever-use after HS diagnosis, compared with participants without HSn = 2,636
Biological age
upin humans1
1 study
Biological age
upin humans1
Hidradenitis suppurativa is associated with biological age in humans (Hidradenitis suppurativa).
ReviewHidradenitis suppurativaAffected skin
Multimorbidity
upin humans1
1 study
Multimorbidity
upin humans1
Hidradenitis suppurativa is linked with a higher risk of multimorbidity in humans (compared with sex- and age-matched controls).
Humanscompared with sex- and age-matched controls
Older-adults
upin humans1
1 study
Older-adults
upin humans1
Older-adults are associated with hidradenitis suppurativa in humans (bootstrap analysis population) (0.8% [95% CI 0.4-1.2]).
Humansbootstrap analysis populationskin
Trial sponsors
Company8 trialsPhase 43,001 people
Novartis Pharmaceuticals Corporation
Company7 trialsPhase 42,815 people
Company7 trialsPhase 32,505 people
Company6 trialsPhase 31,825 people
Company1 trialPhase 392 people
Company3 trialsPhase 2/3293 people
Company1 trialPhase 2435 people
Company1 trialPhase 2300 people
Funding
2 grants since 2019Wellcome TrustZonMw